Movatterモバイル変換

[0]ホーム
URL:

MXPA04004064A - Heteroaromatic carboxamide derivatives for the treatment of inflammation. - Google Patents

Heteroaromatic carboxamide derivatives for the treatment of inflammation.

Info

Publication number
MXPA04004064A
MXPA04004064AMXPA04004064AMXPA04004064AMXPA04004064AMX PA04004064 AMXPA04004064 AMX PA04004064AMX PA04004064 AMXPA04004064 AMX PA04004064AMX PA04004064 AMXPA04004064 AMX PA04004064AMX PA04004064 AMXPA04004064 AMX PA04004064A
Authority
MX
Mexico
Prior art keywords
inflammation
carboxamide derivatives
treatment
heteroaromatic carboxamide
heteroaromatic
Prior art date
Application number
MXPA04004064A
Other languages
Spanish (es)
Inventor
Thao D Perry
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia CorpfiledCriticalPharmacia Corp
Publication of MXPA04004064ApublicationCriticalpatent/MXPA04004064A/en

Links

Classifications

Landscapes

Abstract

The present invention relates to heteroaromatic carboxamide derivatives, compositions comprising such, intermediates, methods of making heteroaromatic carboxamide derivatives, and methods for treating cancer, inflammation, and inflammation-associated disorders, such as arthritis.
MXPA04004064A2001-10-302002-10-30Heteroaromatic carboxamide derivatives for the treatment of inflammation.MXPA04004064A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US34081601P2001-10-302001-10-30
PCT/US2002/034801WO2003037886A2 (en)2001-10-302002-10-30Heteroaromatic carboxamide derivatives for the treatment of inflammation

Publications (1)

Publication NumberPublication Date
MXPA04004064Atrue MXPA04004064A (en)2004-09-06

Family

ID=23335051

Family Applications (1)

Application NumberTitlePriority DateFiling Date
MXPA04004064AMXPA04004064A (en)2001-10-302002-10-30Heteroaromatic carboxamide derivatives for the treatment of inflammation.

Country Status (7)

CountryLink
EP (1)EP1444010A2 (en)
JP (1)JP2005509645A (en)
AU (1)AU2002356871A1 (en)
BR (1)BR0213734A (en)
CA (1)CA2464924A1 (en)
MX (1)MXPA04004064A (en)
WO (1)WO2003037886A2 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6974870B2 (en)2002-06-062005-12-13Boehringer Ingelheim Phamaceuticals, Inc.Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
DK1513516T3 (en)2002-06-062009-10-19Boehringer Ingelheim Pharma Substituted 3-amino-thieno (2,3-b) -pyridine-2-carboxylic acid amide compounds and methods of preparation and their uses
US7199119B2 (en)2002-10-312007-04-03Amgen Inc.Antiinflammation agents
WO2005012283A1 (en)*2003-07-312005-02-10Boehringer Ingelheim Pharmaceuticals, Inc.Substituted benzothiophene compounds and uses thereof
FR2860792B1 (en)2003-10-102006-02-24Sanofi Synthelabo THIOPHENE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
EP1692141A1 (en)*2003-12-052006-08-23Boehringer Ingelheim Pharmaceuticals Inc.Substituted 3-amino-thieno¬2,3-b| pyridine-2-carboxylic acid amide compounds as ikk inhibitors
GB0400895D0 (en)*2004-01-152004-02-18Smithkline Beecham CorpChemical compounds
AU2005228899A1 (en)2004-03-302005-10-13Novartis Vaccines And Diagnostics, Inc.Substituted thiophene derivatives as anti-cancer agents
PE20060373A1 (en)2004-06-242006-04-29Smithkline Beecham Corp 3-PIPERIDINYL-7-CARBOXAMIDE-INDAZOLE DERIVATIVES AS INHIBITORS OF IKK2 KINASE ACTIVITY
TW200626142A (en)2004-09-212006-08-01Glaxo Group LtdChemical compounds
KR100912998B1 (en)2005-03-292009-08-20이코스 코포레이션Heteroaryl urea derivatives useful for inhibiting chk1
GB0507200D0 (en)*2005-04-082005-05-18Smithkline Beecham CorpChemical compounds
US8063071B2 (en)2007-10-312011-11-22GlaxoSmithKline, LLCChemical compounds
TWI380973B (en)2005-06-302013-01-01Smithkline Beecham CorpChemical compounds
EP2474546A1 (en)2006-01-232012-07-11Vertex Pharmaceuticals Inc.Thiophene-carboxamides useful as inhibitors of protein kinases
EP2007757B1 (en)2006-04-132012-10-03Vertex Pharmceuticals IncorporatedThiophene-carboxamides useful as inhibitors of protein kinases
AU2007243457B2 (en)2006-04-262012-02-23F. Hoffmann-La Roche AgPharmaceutical compounds
JP2009538305A (en)*2006-05-232009-11-05バーテックス ファーマシューティカルズ インコーポレイテッド Thiophenecarboxamides useful as inhibitors of protein kinases
JP2009538309A (en)*2006-05-232009-11-05バーテックス ファーマシューティカルズ インコーポレイテッド Thiophenecarboxamides useful as inhibitors of protein kinases
EP2029608A1 (en)2006-06-062009-03-04Boehringer Ingelheim International GmbHSubstituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
WO2008020622A1 (en)*2006-08-172008-02-21Kyorin Pharmaceutical Co., Ltd.NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND
CL2007003520A1 (en)2006-12-072008-08-22Piramed Ltd Genentech Inc COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE PI3 QUINASA ACTIVITY; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE FOR CANCER PROFILACTIC OR THERAPEUTIC TREATMENT.
PE20081889A1 (en)2007-03-232009-03-05Smithkline Beecham Corp INDOL CARBOXAMIDES AS INHIBITORS OF IKK2
CN101932587A (en)2007-09-242010-12-29吉宁特有限公司 Thiazolopyrimidine PI3K inhibitor compounds and methods of use
CA2706571C (en)2007-12-192012-11-27Genentech, Inc.5-anilinoimidazopyridines and methods of use
EP2220092B1 (en)2007-12-212012-06-06Genentech, Inc.Azaindolizines and methods of use
ES2604668T3 (en)2009-02-052017-03-08Immunogen, Inc. New benzodiazepine derivatives
US8354539B2 (en)2009-03-102013-01-15Glaxo Group LimitedIndole derivatives as IKK2 inhibitors
CN102369011A (en)2009-03-122012-03-07健泰科生物技术公司Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
KR20120006543A (en)*2009-04-162012-01-18텔리크 인코포레이티드 Substituted 4-amino-5-benzoyl-2- (phenylamino) thiophen-3-carbonitrile and substituted 4-amino-5-benzoyl-2- (phenylamino) thiophen-3- as tubulin polymerization inhibitors Carboxamide
PH12012500608A1 (en)2009-09-282017-08-09Hoffmann La RocheBenzoxepin pi3k inhibitor compounds and methods of use
WO2011049625A1 (en)2009-10-202011-04-28Mansour SamadpourMethod for aflatoxin screening of products
KR102012398B1 (en)2009-11-052019-08-20리젠 파마슈티컬스 소시에떼 아노님Novel benzopyran kinase modulators
WO2011100403A1 (en)2010-02-102011-08-18Immunogen, IncCd20 antibodies and uses thereof
CN113896731A (en)2011-02-152022-01-07伊缪诺金公司 Cytotoxic benzodiazepine derivatives
AP4075A (en)2011-05-042017-03-23Rhizen Pharmaceuticals S ANovel compounds as modulators of protein kinases
SG11201407537YA (en)2012-06-082014-12-30Hoffmann La RocheMutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
AU2013285081B2 (en)2012-07-042017-01-12Rhizen Pharmaceuticals SaSelective PI3K delta inhibitors
HK1211208A1 (en)2012-08-222016-05-20Immunogen, Inc. Cytotoxic benzodiazepine derivative
JP6423804B2 (en)2013-02-282018-11-14イミュノジェン・インコーポレーテッド Complex containing cell binding agent and cytotoxic agent
US9999680B2 (en)2013-02-282018-06-19Immunogen, Inc.Conjugates comprising cell-binding agents and maytansinoids as cytotoxic agents
WO2014194030A2 (en)2013-05-312014-12-04Immunogen, Inc.Conjugates comprising cell-binding agents and cytotoxic agents
AR104068A1 (en)2015-03-262017-06-21Hoffmann La Roche COMBINATIONS OF A 3-KINASE PHOSFOINOSYTIDE INHIBITOR COMPOSITE AND A CDK4 / 6 INHIBITOR COMPOUND FOR CANCER TREATMENT
WO2018045379A1 (en)2016-09-022018-03-08Dana-Farber Cancer Institute, Inc.Composition and methods of treating b cell disorders
EP3619193B1 (en)*2017-05-052023-03-22Hepanova, Inc.Amino-aryl-benzamide compounds and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1360982A (en)*1970-08-271974-07-24Beecham Group LtdDerivatives of 1-phenyl-5-aminoimidazole and compositions thereof
US3864359A (en)*1972-05-011975-02-04American Cyanamid Co5-amino-3-ethyl-1-phenyl-4-pyrazolecarboxamides and method of preparation thereof
US4264495A (en)*1972-05-151981-04-28Eastman Kodak Company2-Thienyl azo dyestuff compounds
GB1468012A (en)*1973-08-091977-03-23Beecham Group Ltd2-amino-3-carboxy-thiophene derivatives
DD236530A1 (en)*1985-04-261986-06-11Univ Halle Wittenberg PROCESS FOR PREPARING 2-CYANO-2- (4H-4-OXO-1,2, DIHYDRO-THIENO 2,3-D 1,3 THIAZIN-2-YLIDENE) ACETIC ACID ESTERS
DD263055A1 (en)*1987-07-281988-12-21Univ Dresden Tech PROCESS FOR PRODUCING SUBSTITUTED 3-AMINO-5-PHENYL-THIOPHENE
DE3914430A1 (en)*1988-05-051989-11-16Ciba Geigy AgAzo dyes, preparation thereof and use thereof
DE4019168A1 (en)*1989-06-191990-12-20Ciba Geigy AgNew di:hydro-methanobenzocyclooctaquinoline cpds. and azo dyestuff cpd - their prepn. and use as azoic coupler and for dyeing esp. wool and polyamide
GB0003154D0 (en)*2000-02-122000-04-05Astrazeneca Uk LtdNovel compounds
JP2002105081A (en)*2000-07-282002-04-10Nikken Chem Co Ltd New thiopheni ring compounds
AU2002211663A1 (en)*2000-10-122002-04-22Smith Kline Beecham CorporationNf-$g(k)b inhibitors
SE0102616D0 (en)*2001-07-252001-07-25Astrazeneca Ab Novel compounds
WO2003028731A1 (en)*2001-10-042003-04-10Smithkline Beecham CorporationChk1 kinase inhibitors

Also Published As

Publication numberPublication date
CA2464924A1 (en)2003-05-08
EP1444010A2 (en)2004-08-11
WO2003037886A3 (en)2003-12-24
BR0213734A (en)2004-10-19
JP2005509645A (en)2005-04-14
AU2002356871A1 (en)2003-05-12
WO2003037886A2 (en)2003-05-08

Similar Documents

PublicationPublication DateTitle
MXPA04004064A (en)Heteroaromatic carboxamide derivatives for the treatment of inflammation.
MXPA04002070A (en)Substituted indazole compounds for the treatment of inflammation.
MXPA04002682A (en)Substituted pyrazolo compounds for the treatment of inflammation.
WO2003024935A3 (en)Substituted pyrazolyl compounds for the treatment of inflammation
WO2003027075A3 (en)Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
TW200800976A (en)New compounds for the treatment of neurological, psychiatric or pain disorders
NO20034056D0 (en) Proliferative diseases
WO2004041203A3 (en)Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
NZ526868A (en)Substituted alkylamine derivatives and methods of use for treating cancer and angiogenesis related disorders
MY131518A (en)6-substituted pyrido-pyrimidines
TW200510325A (en)2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
AU8490901A (en)Urea compounds and methods of uses
PL351125A1 (en)Derivatives of 4,5-diaryl-3(2)-furanone as inhibitors of cykoxygenease-2
EP1551812A4 (en)Mitotic kinesin inhibitors
EP1463733A4 (en)Mitotic kinesin inhibitors
EP1481077A4 (en)Mitotic kinesin inhibitors
AU2003209118A1 (en)Aryl ureas as kinase inhibitors
MY141528A (en)Anilinopyrazole derivatives useful for the treatment of diabetes
GB0111186D0 (en)Novel compounds
TNSN04015A1 (en)Combination therapy for the treatment of cancer
AU2002367172A1 (en)2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
PL372179A1 (en)Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
MY158159A (en)Novel fused pyrrolocarbazoles
MY149041A (en)Novel fused pyrrolocarbazoles
MXPA03007653A (en)Use of lp82 to treat hematopoietic disorders.
[8]ページ先頭
©2009-2025 Movatter.jp